Sleep Disorders Unit, Yedikule Chest Disease and Thoracic Surgery Research and Education Hospital, Istanbul, Turkey.
Lung. 2010 Aug;188(4):315-20. doi: 10.1007/s00408-010-9237-4. Epub 2010 Apr 7.
The effect of positive airway pressure treatments in different modalities on the cardiovascular consequences of the disease in sleep apnea patients is still unclear. We aimed to compare auto-titrating positive airway pressure (APAP) and conventional continuous positive airway pressure (CPAP) in terms of improving heart rate variability (HRV) in obstructive sleep apnea patients. This was a prospective study done in a tertiary research hospital. All patients underwent a manual CPAP titration procedure to determine the optimal pressure that abolishes abnormal respiratory events. Then patients underwent two treatment nights, one under APAP mode and one under conventional CPAP mode with a 1-week interval. Forty newly diagnosed obstructive sleep apnea patients were enrolled in the study. We compared heart rate variability analysis parameters between the APAP night and the CPAP night. This final analysis included the data of 28 patients (M/F: 22/6; mean age = 46 +/- 10 years). Sleep characteristics were comparable between the two treatment nights, whereas all-night time domains of HRV analysis such as HF, nuLF, and LF/HF were different between APAP and CPAP nights (2.93 +/- 0.31 vs. 3.01 +/- 0.31; P = 0.041; 0.75 +/- 0.13 vs. 0.71 +/- 0.14; P = 0.027; and 4.37 +/- 3.24 vs. 3.56 +/- 2.07; P = 0.023, respectively). HRV analysis for individual sleep stages showed that Stage 2 LF, nuLF, nuHF, LF/HF parameters entirely improved under CPAP treatment whereas APAP treatment resulted in nonsignificant changes. These results suggest that despite comparable improvement in abnormal respiratory events with APAP or CPAP treatments, CPAP may be superior to APAP in terms of correcting cardiovascular alterations in sleep apnea patients.
不同模式的正压通气治疗对睡眠呼吸暂停患者疾病心血管后果的影响仍不清楚。我们旨在比较自动滴定正压通气(APAP)和传统持续正压通气(CPAP)在改善阻塞性睡眠呼吸暂停患者心率变异性(HRV)方面的效果。这是在一家三级研究医院进行的前瞻性研究。所有患者均接受手动 CPAP 滴定程序以确定消除异常呼吸事件的最佳压力。然后,患者进行了两个治疗夜,一个在 APAP 模式下,一个在传统 CPAP 模式下,间隔 1 周。40 例新诊断的阻塞性睡眠呼吸暂停患者纳入研究。我们比较了 APAP 夜间和 CPAP 夜间的心率变异性分析参数。最终分析包括 28 例患者的数据(M/F:22/6;平均年龄=46±10 岁)。两个治疗夜间的睡眠特征相似,而整夜 HRV 分析的时域,如 HF、nuLF 和 LF/HF,在 APAP 和 CPAP 夜间不同(2.93±0.31 vs. 3.01±0.31;P=0.041;0.75±0.13 vs. 0.71±0.14;P=0.027;4.37±3.24 vs. 3.56±2.07;P=0.023)。个别睡眠阶段的 HRV 分析显示,CPAP 治疗可完全改善 Stage 2 LF、nuLF、nuHF、LF/HF 参数,而 APAP 治疗则无明显变化。这些结果表明,尽管 APAP 或 CPAP 治疗均可改善异常呼吸事件,但 CPAP 在纠正睡眠呼吸暂停患者的心血管改变方面可能优于 APAP。